| Detected | Trial | Change |
|---|---|---|
| 2026-07-25 | NCT06137768 A Trial of HRS-5965 Tablets in Primary IgA Nephropathy |
Trial completed |
| 2026-07-25 | NCT06137768 A Trial of HRS-5965 Tablets in Primary IgA Nephropathy |
date change Primary completion pushed: 2024-12-01 -> 2025-10-17 |
| 2026-07-25 | NCT06137768 A Trial of HRS-5965 Tablets in Primary IgA Nephropathy |
date change Completion pushed: 2025-08-31 -> 2025-10-17 |
| 2026-07-23 | NCT07582133 A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With… |
Recruitment opened |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07014826 | A Trial of HRS-5965 Capsule in Primary IgA Nephropathy | Primary IgA Nephropathy | Recruiting |
| Phase 2 | |||
| NCT07582133 | A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With… | Primary IgA Nephropathy | Recruiting |
| NCT06238544 | Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal… | Paroxysmal Nocturnal Hemoglobinuria | Active, Not Recruiting |
| NCT07613866 | A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous Urticaria | Chronic Spontaneous Urticaria | Not Yet Recruiting |
| Phase 1 | |||
| NCT07551167 | A Clinical Study of HRS-5765 in Healthy Participants | Heart Failure | Recruiting |
| NCT07583212 | Phase I Study of HRS-1635 in B-cell Malignancies | B-cell Malignancy | Recruiting |
| NCT07698756 | A Clinical Study of HRS-8797 in Healthy Participants | Atopic Dermatitis | Not Yet Recruiting |